scispace - formally typeset
Y

Yunman Li

Researcher at China Pharmaceutical University

Publications -  134
Citations -  3132

Yunman Li is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Ischemia & Neuroprotection. The author has an hindex of 27, co-authored 125 publications receiving 2318 citations.

Papers
More filters
Journal ArticleDOI

Neuroprotection by the soy isoflavone, genistein, via inhibition of mitochondria-dependent apoptosis pathways and reactive oxygen induced-NF-κB activation in a cerebral ischemia mouse model.

TL;DR: It is suggested that genistein has a neuroprotective effect in transient focal ischemia, which may involve regulation of mitochondria-dependent apoptosis pathways and suppression of ROS-induced NF-κB activation.
Journal ArticleDOI

Enhancement of transdermal delivery of theophylline using microemulsion vehicle.

TL;DR: Results of studies showed that microemulsion system of theophylline might be promising vehicles for the transdermal delivery of thephylline.
Journal ArticleDOI

Anti-inflammatory effects of maslinic acid, a natural triterpene, in cultured cortical astrocytes via suppression of nuclear factor-kappa B.

TL;DR: Results suggest that maslinic acid can potentially reduce neuroinflammation by inhibiting NF-κB signal transducer pathway in cultured cortical astrocytes.
Journal ArticleDOI

Maslinic acid, a natural inhibitor of glycogen phosphorylase, reduces cerebral ischemic injury in hyperglycemic rats by GLT‐1 up‐regulation

TL;DR: It is demonstrated that, in addition to showing promising antidiabetic properties, MA has a direct beneficial effect in cerebral ischemic injury, which may be correlated with the promotion of glutamate clearance by NF‐κB‐mediated GLT‐1 up‐regulation.
Journal ArticleDOI

Berberine attenuates ischemia–reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation

TL;DR: It is demonstrated that berberine protects the brain from ischemia–reperfusion injury and the mechanism may rely on its anti-inflammatory effects mediated by suppressing the activation of HMGB1/TLR4/NF-κB signaling.